If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWeir Group Regulatory News (WEIR)

Share Price Information for Weir Group (WEIR)

Share Price is delayed by 15 minutes
Get Live Data
2,342.00    4.00 (0.17%)
Bid:
2,340.00
Ask:
2,342.00
Spread: 2.00 (0.085%)
Market Cap: £6.08b
WEIR Live PriceLast checked at - London Stock Exchange

Intraday Weir Group Share Chart

Directorate Change

23 Apr 2018 14:49

RNS Number : 8165L
Weir Group PLC
23 April 2018
 

23 April 2018

The Weir Group PLC

LEI Number: 549300KDR56WHY9I3D10

 

 

Directorate Change

The Weir Group PLC ("Weir") announces the appointment of Calvin Collins to the Board as a Non-Executive Director with effect from the closing of Weir's proposed acquisition of ESCO Corporation ("ESCO"). His start date will be announced in due course.

Mr Collins has been the Chief Executive Officer and President of ESCO since 1 January 2012 and 1 January 2011 respectively. Prior to this, Mr Collins served in a variety of roles at ESCO since 2000.

Mr Collins' appointment follows the announcement of Weir's acquisition of ESCO on 19 April 2018.

There are no further details to be disclosed relating to Calvin Collins under section 9.6.13 of the Listing Rules.

 

For further information, please contact:

 

 

Christopher Morgan

Company Secretary

Telephone: 0141 308 3771

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAFKNDQNBKDFQB
Date   Source Headline
18th Jun 202512:00 pmRNS-RWeir's Townley acquisition strengthens NA presence
17th Jun 202511:00 amRNSChange in external auditor
13th Jun 20253:49 pmRNSDirector/PDMR Shareholding
11th Jun 20257:00 amRNSWeir awarded £40m sustainable tailings contracts
3rd Jun 202510:44 amRNSDirector/PDMR Shareholding
23rd May 20252:29 pmRNSDirector/PDMR Shareholding
14th May 202511:43 amRNSDirector/PDMR Shareholding
12th May 202510:00 amRNS-RWeir and CiDRA announce collaboration agreement
9th May 20253:48 pmRNSDirector/PDMR Shareholding
30th Apr 20257:00 amRNSWeir completes acquisition of Micromine
25th Apr 20258:27 amRNSDirectorate Change
24th Apr 20254:25 pmRNSResult of AGM
24th Apr 20257:00 amRNSQ1 Trading Update
16th Apr 20253:19 pmRNSDirector/PDMR Shareholding
15th Apr 20255:00 pmRNSDirector/PDMR Shareholding
15th Apr 20254:58 pmRNSDirector/PDMR Shareholding
15th Apr 20254:56 pmRNSDirector/PDMR Shareholding
14th Apr 202510:24 amRNSDirector/PDMR Shareholding
14th Apr 202510:18 amRNSDirector/PDMR Shareholding
10th Apr 202512:28 pmRNSDirector/PDMR Shareholding
10th Apr 202512:28 pmRNSDirector/PDMR Shareholding
1st Apr 202511:20 amRNSDirector/PDMR Shareholding
1st Apr 202511:19 amRNSDirector/PDMR Shareholding
21st Mar 20251:46 pmRNS2024 Annual Report and 2025 Annual General Meeting
17th Mar 20251:07 pmRNSHolding(s) in Company
13th Mar 20251:58 pmRNSDirectorate Change
3rd Mar 20251:46 pmRNSDirector/PDMR Shareholding
28th Feb 202511:27 amRNSCLARIFICATION REGARDING ACQUISITION ANNOUNCEMENT
28th Feb 20257:01 amRNSAcquisition
28th Feb 20257:00 amRNSFinal Results
20th Nov 202410:13 amRNSHolding(s) in Company
5th Nov 20244:31 pmRNSDirector/PDMR Shareholding
5th Nov 20247:00 amRNSQ3 Trading Update
30th Sep 202412:31 pmRNSDirector/PDMR Shareholding
30th Sep 20247:00 amRNSWeir awarded £25m contract
11th Sep 20249:28 amRNSDirector/PDMR Shareholding
20th Aug 20247:00 amRNSWeir awarded £53m redefined flowsheet contract
30th Jul 20247:00 amRNSHalf-year Report
25th Jun 202411:28 amRNSHolding(s) in Company
3rd Jun 20245:24 pmRNSDirector/PDMR Shareholding
28th May 202412:03 pmRNSDirector/PDMR Shareholding
23rd May 20244:58 pmRNSDirector/PDMR Shareholding
15th May 20247:39 amRNSDirectorate Change
13th May 20249:54 amRNSHolding(s) in Company
25th Apr 20244:06 pmRNSResult of AGM
25th Apr 20247:00 amRNSQ1 Trading Update
15th Apr 20245:21 pmRNSDirector/PDMR Shareholding
15th Apr 20244:28 pmRNSDirector/PDMR Shareholding
15th Apr 20244:19 pmRNSDirector/PDMR Shareholding
15th Apr 20244:18 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.